Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ChronTech Pharma AB

www.tripep.se

Latest From ChronTech Pharma AB

Roche Adds To Its Immuno-Oncology Investments With Inovio Licensing Deal

Swiss pharma licenses rights to a pair of preclinical, multi-antigen DNA immunotherapies for prostate cancer and hepatitis B, as well as delivery technology. Inovio gets $10 million up front and can earn milestones up to $412.5 million.

BioPharmaceutical United States

Scrip Asia 100 - Asia's shining stars

The Scrip Asia 100 analysis identifies 100 of the most influential players on the Asia-Pacific life sciences scene. Our shining stars are 10 of Asia's visionary leaders from the worlds of pharma business and science.

Dermatology Immune Disorders

Deals Shaping the Medical Industry (09/2009)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

Europe venture to take on Kringle's lead project

Kringle Pharma has set up its first overseas operation, a European subsidiary which will progress the clinical development of its lead recombinant hepatic growth factor therapy.

Dermatology Wound Healing & Tissue Repair
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Tripep AB
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Sweden
  • Parent & Subsidiaries
  • ChronTech Pharma AB
  • Senior Management
  • Anders Vahlne, CEO & Head, Research
    Asa Ekstrand, CFO
  • Contact Info
  • ChronTech Pharma AB
    Phone: (46) 8 449 84 80
    Halsovagen 7
    Huddinge, SE 141 57
    Sweden
UsernamePublicRestriction

Register